drugset

drugset / Trial / NCT06346340

A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy

NCT06346340 ↗

Phase 4 Completed 97 enrolled Bausch & Lomb Incorporated

NaSingle-groupOpen-labelTreatment

Summary

A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/ Keratometry and Postoperative Refractive Accuracy

Timeline

Start: 2024-04-30
Primary completion: 2025-02-24
Completion: 2025-02-24

Publications

Hovanesian JA, Liang E, Desai NR, Berdy GJ, Karpuk K, Schweitzer J, Alexander A, Vittitow JL, Berdahl J, Bacharach J. Perfluorohexyloctane Ophthalmic Solution in Patients with Dry Eye Disease Undergoing Cataract Surgery: A Prospective Multicenter Study. Ophthalmol Ther. 2026 Feb;15(2):817-829. doi: 10.1007/s40123-025-01302-z. Epub 2026 Jan 26.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Perfluorohexyloctane	Unknown	—	Other

Indications